A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Last updated: April 15, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer/tumors

Multiple Myeloma

Leukemia

Treatment

Placebo supplements

Whole Foods Plant-based Diet

Algae omega 3

Clinical Study ID

NCT05640843
22-175
  • Ages > 18
  • All Genders

Study Summary

The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substance that looks like the study supplements) affect butyrate levels in participants' stool.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Confirmed diagnosis of MGUS or SMM

  • If non light chain MGUS/SMM then M spike must be either ≥ 0.2 g/dL or BM PC ≥10% (both not required)

  • If light chain MGUS/SMM then involved must be ≥10 mg/dL or BM PC ≥10% (both notrequired)

  • If IgA MGUS/SMM then an IgA level >350 mg/dL and an abnormal immunofixation isrequired (M spike criteria not required).

  • If IgD MGUS/SMM then an IgD level >50 mg/dL and an abnormal immunofixation isrequired (M spike criteria not required).

  • Age ≥18 years

  • Willingness to comply with all study-related procedures

  • ECOG performance status of 0-3

  • Interested in learning to cook plant based recipes

Exclusion

Exclusion Criteria:

  • Patients that already follow a whole foods plant based diet (ovo-lacto-vegetarian orprocessed junk food vegan diets are not excluded)

  • Legume allergy

  • Severe allergies such as anaphylactic shock to nuts (specifically cashews). Peanutsare not included in the meals.

  • Concurrent participation in weight loss/dietary/exercise programs

  • Mental impairment leading to inability to cooperate

  • Enrollment onto any other therapeutic investigational study concurrently and up to 180 days prior to study start date

  • Concurrent pregnancy

  • Positive HBV, HCV or HIV PCR test will need to be treated first and onceundetectable viral load patients may enroll

  • ≥ Grade 2 electrolyte abnormalities as defined by CTCAEv5.0 (need to be resolvedbefore enrolling on study)

  • If in the opinion of the investigator there maybe any concerns regarding the abilityof the patient to complete the study safely or any contraindications

  • Heavy drinker (defined as >2 drinks per day or >14 drinks per week)

  • Current self-reported illicit drug use (eg heroin, cocaine not marijuana)

  • Plan for prolonged travel during the study that would preclude adherence toprescribed diets

  • History of major gastrointestinal surgery (not including appendectomy orcholecystectomy) within 3 months of enrollment

  • If already taking curcumin or omega 3 supplements patients must be willing to stopit on the date of trial consent for study duration.

Study Design

Total Participants: 180
Treatment Group(s): 4
Primary Treatment: Placebo supplements
Phase:
Study Start date:
November 29, 2022
Estimated Completion Date:
November 30, 2026

Connect with a study center

  • Emory University (Data Collection Only)

    Atlanta, Georgia 30322
    United States

    Active - Recruiting

  • Emory University (Data Collection Only)

    Atlanta 4180439, Georgia 4197000 30322
    United States

    Site Not Available

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

    Basking Ridge, New Jersey 07920
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Monmouth (All Protocol Activities)

    Middletown, New Jersey 07748
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Bergen (All Protocol Activities)

    Montvale, New Jersey 07645
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

    Basking Ridge 5095409, New Jersey 5101760 07920
    United States

    Site Not Available

  • Memorial Sloan Kettering Monmouth (All Protocol Activities)

    Middletown 5101170, New Jersey 5101760 07748
    United States

    Site Not Available

  • Memorial Sloan Kettering Bergen (All Protocol Activities)

    Montvale 5101361, New Jersey 5101760 07645
    United States

    Site Not Available

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)

    Commack, New York 11725
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Westchester (All Protocol Activities)

    Harrison, New York 10604
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York 10065
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Nassau (All Protocol Activities)

    Uniondale, New York 11553
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)

    Commack 5113412, New York 5128638 11725
    United States

    Site Not Available

  • Memorial Sloan Kettering Westchester (All Protocol Activities)

    Harrison 5120095, New York 5128638 10604
    United States

    Site Not Available

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York 5128581, New York 5128638 10065
    United States

    Site Not Available

  • Memorial Sloan Kettering Nassau (All Protocol Activities)

    Uniondale 5141927, New York 5128638 11553
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.